Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Board Changes

10 Apr 2025 07:00

RNS Number : 3758E
Wilmington PLC
10 April 2025
 

10 April 2025

 

Wilmington plc

 

Board change

 

Wilmington plc (LSE: WIL, 'Wilmington', 'the Group'), the provider of data, information, education and training in the global Governance, Risk and Compliance markets, today announces that Martin Morgan will retire as Chair with effect from 23 June 2025 and will be replaced as Chair and as a director of the Group by Gordon Hurst from that date. Gordon will also join the Nomination and Remuneration Committees.

 

Gordon worked at Capita plc as Group Finance Director from 1996 to 2015 and has followed a plural non-executive career since then, including being Non-Executive Chair of Darktrace plc from 2021 to 2024, Azets from 2019 to 2023, Featurespace from 2014 to 2023 and Marston Holdings from 2016 to 2021 and a Non-Executive Director of Motorpoint plc from 2016 to 2021. Gordon is currently Non-Executive Chairman of Cadro Technologies (since May 2024) and Air IT (since August 2024).

 

Gordon is a qualified chartered accountant and member of the ICAEW.

 

Helen Sachdev, Senior Independent Director of Wilmington, said

 

"Gordon brings a wealth of experience and relevant expertise, from both his non-executive and his executive careers. We look forward to him joining the Board.

 

"On behalf of the Board, I'd like to thank Martin for his considerable contribution over seven years as Chair of Wilmington."

 

There are no additional disclosures required under Listing Rule 9.6.13 R (1) to (6) in relation to the appointment of Gordon Hurst.

 

For further information, contact:

Wilmington plc

Guy Millward, CFO and Company Secretary

 

Meare Consulting

Adrian Duffield

020 7490 0049

 

 

 

07990 858548

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs over 650 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGDDLLGKZM
Date   Source Headline
8th Jul 20193:54 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSExtension of debt facility
1st Jul 20195:11 pmRNSTotal Voting Rights
28th Jun 20197:00 amRNSWilmington plc Pre-close Trading Update
10th Jun 20194:41 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSTotal Voting Rights
17th May 201912:13 pmRNSHolding(s) in Company
17th May 20199:21 amRNSHolding(s) in Company
16th May 20197:00 amRNSAppointment of Mark Milner as CEO
8th May 20197:00 amRNSChange of Company Secretary
3rd May 201911:18 amRNSDirector Declaration
1st May 20197:00 amRNSTotal Voting Rights
2nd Apr 20192:20 pmRNSTotal Voting Rights
1st Apr 20197:00 amRNSSAYE and Director/PDMR Shareholding
1st Mar 201911:00 amRNSHolding(s) in Company
1st Mar 201910:58 amRNSTotal Voting Rights
21st Feb 20197:00 amRNSResults for the six months ended 31 December 2018
14th Feb 201910:19 amRNSDirectorate Change Update
1st Feb 20193:53 pmRNSTotal Voting Rights
28th Jan 20194:44 pmRNSHolding(s) in Company
16th Jan 20197:00 amRNSDirectorate Change
2nd Jan 201910:33 amRNSTotal Voting Rights
14th Dec 20184:43 pmRNSNotification of Interim Results
3rd Dec 20187:00 amRNSTotal Voting Rights
14th Nov 20187:00 amRNSNew Joint Venture Agreement
1st Nov 20182:07 pmRNSResult of AGM
1st Nov 20187:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20187:00 amRNSTotal Voting Rights
17th Oct 20185:13 pmRNSHolding(s) in Company
1st Oct 20185:44 pmRNSDirector/PDMR Shareholding
1st Oct 201810:18 amRNSTotal Voting Rights
25th Sep 201812:29 pmRNSHolding(s) in Company
21st Sep 20183:13 pmRNSDirector/PDMR Shareholding
20th Sep 20183:19 pmRNSDirector/PDMR Shareholding
19th Sep 20182:12 pmRNSShare Awards
12th Sep 20187:00 amRNSFinancial results for the year ended 30 June 2018
3rd Sep 20189:00 amRNSTotal Voting Rights
28th Aug 201810:39 amRNSHolding(s) in Company
1st Aug 20189:00 amRNSTotal Voting Rights
19th Jul 20187:00 amRNSSale of ICP Credit Reporting Business
10th Jul 20184:24 pmRNSHolding(s) in Company
10th Jul 20184:19 pmRNSHolding(s) in Company
9th Jul 20182:23 pmRNSHolding(s) in Company
6th Jul 20187:00 amRNSTrading Statement
2nd Jul 201810:29 amRNSVoting Rights and Capital
1st Jun 20189:00 amRNSTotal Voting Rights
9th May 20187:00 amRNSCapital Markets Day
1st May 20187:00 amRNSTotal Voting Rights
3rd Apr 20187:00 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.